Back
Equity Residential Vs. Viking Therapeutics Industry Stock Comparison
Buy
68
EQR
Equity Residential
Last Price:
69.32
Seasonality Move:
2.37%
Sell
47
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Buy
68
Equity Residential (EQR)
is a Buy
Is Equity Residential a Buy, Sell or Hold?
- The current Equity Residential [EQR] share price is $69.34. The Score for EQR is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- EQR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EQR Stock Price Chart
What is Equity Residential's stock price today?
-
The Equity Residential share price today is $69.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EQR is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
EQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 67.08 | Buy |
| Chaikin Money Flow: | 1240903 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.79 - 67.99) | Buy |
| Bollinger Bands (100): | (60.77 - 66.47) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.9 | Sell |
| Relative Strength Index (14 RSI): | 43.41 | Sell |
| Chaikin Money Flow: | 113403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 60.74) | Sell |
| Bollinger Bands (100): | (47.23 - 79.29) | Sell |
EQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.43 | Buy |
| 20-day SMA: | 66.83 | Buy |
| 50-day SMA: | 65.93 | Buy |
| 200-day SMA: | 61.24 | Buy |
| 8-day EMA: | 68.27 | Buy |
| 20-day EMA: | 67.27 | Buy |
| 50-day EMA: | 65.87 | Buy |
| 200-day EMA: | 63.19 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.6 | Buy |
| 20-day SMA: | 53.66 | Sell |
| 50-day SMA: | 63.66 | Sell |
| 200-day SMA: | 39.18 | Buy |
| 8-day EMA: | 51.13 | Buy |
| 20-day EMA: | 54.21 | Sell |
| 50-day EMA: | 59.37 | Sell |
| 200-day EMA: | 45.7 | Buy |
Equity Residential Earnings Growth & EQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.05 per share, and an increase next year of $0.19 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Equity Residential Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||